Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Projection Of Mesothelioma Mortality In Britain Using Bayesian Methods

E. Tan, N. Warren, A. Darnton, J. Hodgson
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Background:Mesothelioma mortality has increased more than ten-fold over the past 40 years in Great Britain, with >1700 male deaths recorded in the British mesothelioma register in 2006. Annual mesothelioma deaths now account for >1% of all cancer deaths. A Poisson regression model based on a previous work by Hodgson et al has been fitted, which has allowed informed statistical inferences about model parameters and predictions of future mesothelioma mortality to be made.Methods:In the Poisson regression model, the mesothelioma risk of an individual depends on the average collective asbestos dose for the individual in a given year and an age-specific exposure potential. The model has been fitted to the data within a Bayesian framework using the Metropolis–Hastings algorithm, a Markov Chain Monte Carlo technique, providing credible intervals for model parameters as well as prediction intervals for the number of future cases of mortality.Results:Males were most likely to have been exposed to asbestos between the ages of 30 and 49 years, with the peak year of asbestos exposure estimated to be 1963. The estimated number of background cases was 1.08 cases per million population.Conclusion:Mortality among males is predicted to peak at approximately 2040 deaths in the year 2016, with a rapid decline thereafter. Approximately 91 000 deaths are predicted to occur from 1968 to 2050 with around 61 000 of these occurring from 2007 onwards.
This paper references
Amendment to the Control of Asbestos at Work Regulations 1987 and AcoP: Regulatory Impact Assessment. Health and Safety Executive
Hse (1998)
10.1136/oem.55.11.760
Estimation of the past and future burden of mortality from mesothelioma in France.
A. G. Ilg (1998)
10.1136/oem.57.7.488
Future trends in mortality of French men from mesothelioma
A. Banaei (2000)
10.1136/oem.2006.031823
Projected mesothelioma incidence in men in New South Wales
M. Clements (2007)
10.1038/sj.bjc.6604879
Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study
C. Rake (2009)
10.1038/sj.bjc.6602307
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
J. Hodgson (2005)
Teller E (1953) Equations of state calculations by fast computing machines
N Metropolis
10.1016/S0140-6736(95)90462-X
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
10.1179/oeh.2003.9.3.206
Malignant Mesothelioma in Australia, 1945–2002
J. Leigh (2003)
10.1097/CEJ.0b013e3282f0c0a2
US mesothelioma patterns 1973–2002: indicators of change and insights into background rates
M. J. Teta (2008)
Malignant mesothelioma in Australia
A. Musk (2006)
10.1093/BIOMET/57.1.97
Monte Carlo Sampling Methods Using Markov Chains and Their Applications
W. Hastings (1970)
10.1136/oem.60.1.50
Update of predictions of mortality from pleural mesothelioma in the Netherlands
O. Segura (2003)
10.2307/2343871
The Age Distribution of Cancer: Implications for Models of Carcinogenesis
R. Doll (1971)
10.1063/1.1699114
Equation of state calculations by fast computing machines
N. Metropolis (1953)
10.1183/09031936.96.09091932
The epidemiology of mesothelioma in historical context.
J. C. Mcdonald (1996)
10.1038/bjc.1982.15
Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment.
J. Peto (1982)



This paper is referenced by
10.5380/CE.V21I2.46833
IMPACTO DA EXPOSIÇÃO AO AMIANTO NA SAÚDE DA POPULAÇÃO ADULTA: REVISÃO INTEGRATIVA
Fátima Denise Padilha Baran (2016)
10.3892/ijo.2016.3335
KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma.
S. Cregan (2016)
KAT 5 ( Tip 60 ) is a potential therapeutic target in malignant pleural mesothelioma
S. Cregan ()
10.1136/oemed-2015-103074
Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden
C. Gilham (2015)
10.4225/50/57CDFEBB71B93
Review of the effectiveness of predictive models for mesothelioma to identify lessons for asbestos-related policy
Alison Reid (2016)
10.1183/20734735.001011
Mesothelioma: an update
T. Berghmans (2011)
10.1038/bjc.2012.135
Estimating the burden of occupational cancer as a strategic step to prevention
K. Straif (2012)
10.1289/ehp.1205897
Environmental and Occupational Interventions for Primary Prevention of Cancer: A Cross-Sectorial Policy Framework
C. Espina (2013)
10.15406/JLPRR.2016.03.00085
Malignant pleural mesothelioma: occupational and non-occupational asbestos exposures
A. Cheepsattayakorn (2016)
10.1038/bjc.2012.125
Occupational cancer in Britain
Y. Chen (2012)
10.1111/crj.12028
Asbestos and the lung in the 21st century: an update
Silvie Prazakova (2014)
10.1093/occmed/kqv142
UK asbestos imports and mortality due to idiopathic pulmonary fibrosis.
C. Barber (2016)
10.1016/j.canep.2014.08.007
Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region.
P. Girardi (2014)
10.1634/theoncologist.2014-0122
Current issues in malignant pleural mesothelioma evaluation and management.
J. Ai (2014)
10.1016/j.lungcan.2015.03.005
Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
P. Beckett (2015)
10.1136/oemed-2016-103652
Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections
C. Mensi (2016)
10.1111/RSSA.12051
Inference and forecasting in the age-period-cohort model with unknown exposure with an application to mesothelioma mortality
M. D. M. Miranda (2013)
Kdm 6 a and Kdm 6 b : Altered expression in malignant pleural mesothelioma
S. Cregan (2017)
10.30757/ALEA.V15-33
In-sample forecasting: A brief review and new algorithms
Young Kyung Lee (2018)
10.1016/j.ejca.2012.02.047
Rare thoracic cancers, including peritoneum mesothelioma.
S. Siesling (2012)
10.1111/j.1440-1843.2011.02020.x
Facts, rumours and speculations about the mesothelioma epidemic
J. Van Meerbeeck (2011)
10.1002/jcp.22724
Malignant mesothelioma: Facts, Myths, and Hypotheses
M. Carbone (2012)
10.1007/978-3-030-16884-1_1
Epidemiology of Mesothelioma
D. Mirabelli (2019)
10.3390/ijerph17020607
Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use
E. Oddone (2020)
10.1097/CAD.0b013e328341ccdd
Targeted therapies in malignant pleural mesothelioma: a review of clinical studies
L. Greillier (2011)
10.1007/978-1-4614-5586-8_3
Prevention of Occupationally Induced Cancer
A. Blair (2013)
10.1002/ijc.26229
Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register
A. Marinaccio (2012)
BC DISEASE NEWS
A. Weekly (2013)
University of Groningen Rare thoracic cancers , including peritoneum mesothelioma
Sabine Siesling (2017)
10.3892/ijo.2017.3870
Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
S. Cregan (2017)
10.3238/arztebl.2013.0319
Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.
V. Neumann (2013)
10.32614/RJ-2015-020
apc: An R Package for Age-Period-Cohort Analysis
Bent Nielsen (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar